Want to see HELE full AI Analyst Report?
Top Page
Helen Of Troy
(NASDAQ:HELE)
Select Model
Select Model
Rating:54Neutral
Price Target:
$29.00
▲(53.76% Upside)
Action:Reiterated
Date:07/08/26
The score is held back primarily by weak financial performance driven by steep recent losses and higher leverage risk, despite positive cash flow. Technicals are a key support with a clear uptrend and healthy (not overextended) momentum. Earnings-call commentary is moderately positive due to reiterated guidance, Q1 outperformance, and deleveraging, but margin compression and tariff/inflation uncertainty limit upside. Valuation remains challenged given the negative P/E and no provided dividend yield.
Positive Factors
Cash generation
Helen of Troy continues to produce positive operating cash flow (~$112M TTM) and free cash flow (~$86M TTM). Durable cash generation provides liquidity to support working capital, debt paydown, targeted capex and brand investments, cushioning near-term operational volatility.
Negative Factors
Profitability deterioration
Trailing results show a sharp drop to a large net loss and negative operating profit (TTM net margin near -50%). Persistent unprofitability erodes returns, constrains reinvestment ability, and raises the probability of structural remediation or more aggressive cost actions if margins do not recover.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Helen of Troy continues to produce positive operating cash flow (~$112M TTM) and free cash flow (~$86M TTM). Durable cash generation provides liquidity to support working capital, debt paydown, targeted capex and brand investments, cushioning near-term operational volatility.
Read all positive factors
Helen Of Troy Key Performance Indicators (KPIs)
Any
Revenue By Segment
Analyzes revenue from different business segments, revealing which product lines or services are contributing most to growth and which might need strategic attention.
Analyzes revenue from different business segments, revealing which product lines or services are contributing most to growth and which might need strategic attention.
Data provided by:
The Fly
The FlyHelen Of Troy (HELE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$638.90M
Dividend YieldN/A
Average Volume (3M)549.10K
Price to Earnings (P/E)―
Beta (1Y)1.09
Revenue Growth-2.08%
EPS Growth-23.88%
CountryUS
Employees1,883
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-17.99
Shares Outstanding23,292,060
10 Day Avg. Volume597,502
30 Day Avg. Volume549,095
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.51
Price to Sales (P/S)0.23
P/FCF Ratio3.08
Enterprise Value/Market Cap2.24
Enterprise Value/Revenue0.79
Enterprise Value/Gross Profit1.73
Enterprise Value/Ebitda-5.48
Forecast
1Y Price Target
$26.50Price Target Upside40.51% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)3.49
Revenue Forecast (FY)$1.79B
Helen Of Troy Business Overview & Revenue Model
Company Description
Helen of Troy Limited is a global consumer products enterprise that markets a diverse array of goods across the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company's operations are struct...
How the Company Makes Money
Helen of Troy primarily makes money by selling branded consumer products to retail and e-commerce customers on a wholesale basis, with revenue recognized from product sales across its operating segments (notably Home & Outdoor and Beauty & Wellnes...
Helen Of Troy Earnings Call Summary
Earnings Call Date:Jul 08, 2026
(Q1-2027)
| % Change Since: |
Next Earnings Date:Oct 07, 2026
Earnings Call Sentiment Positive
The call presented a generally constructive operational and financial start to fiscal 2027: Q1 sales growth (+8.2%) and segment gains (Home & Outdoor +9.5%, Beauty & Wellness +7%) beat expectations, debt was materially reduced and inventory improved, and management is investing in a new operating model and brand initiatives. However, notable headwinds persist — gross margin compression (~110 bps), ongoing tariff and inflationary pressure, supply-chain and geopolitical risk, one-time items affecting SG&A, and near-term cadence risk (possible second-half revenue decline). On balance, the positive delivery of better-than-expected top-line performance, deleveraging and clear strategic actions outweigh the near-term margin and macro risks.Positive Updates
Consolidated Sales Growth Outperformed Expectations
Net sales increased 8.2% year over year in Q1, coming in above company expectations; Q1 results benefited from ~$4–$5M favorable order phasing from earlier Prime Day timing.
Negative Updates
Gross Margin Compression
Consolidated gross profit margin decreased by 110 basis points to 46.0% year over year, driven by net unfavorable tariff impact, higher inventory obsolescence, and unfavorable customer mix within Home & Outdoor.
Read all updates
Q1-2027 Updates
Positive
Negative
Consolidated Sales Growth Outperformed Expectations
Net sales increased 8.2% year over year in Q1, coming in above company expectations; Q1 results benefited from ~$4–$5M favorable order phasing from earlier Prime Day timing.
Read all positive updates
Company Guidance
Management reiterated full‑year net sales guidance of $1.759–$1.831 billion (Home & Outdoor $859–$884M; Beauty & Wellness $900–$947M), maintained adjusted EBITDA of $190–$197M (implying +2.1% to +6.3% YoY) and adjusted EPS of $3.25–$3.75, and kept full‑year free cash flow at $85–$100M while raising planned capital expenditures by $2M; Q1 results beat expectations with consolidated sales +8.2% (helped by ~$4–$5M Prime Day order phasing), Home & Outdoor +9.5%, Beauty & Wellness +7.0%, International +1.1%, but Q1 free cash flow was slightly negative. Key margin and balance‑sheet metrics: consolidated gross margin down 110 bps to 46%, SG&A ratio 31% (vs. 45.1% LY, aided by a $55M pretax gain on a facility sale), adjusted operating margin 4% (down 30 bps), inventory $467M (down $17M YoY despite ~ $15M incremental tariffs in inventory), total debt reduced by $716M and net leverage to 3.48x (from 3.87x). Guidance embeds a Phase 1 tariff refund benefit now estimated at ~$9.2M (Q1 included a $1.8M pretax benefit), notes $71M of EPA tariffs paid not in Phase 1, expects H1 sales growth low‑ to mid‑single digits and a second‑half low‑single‑digit decline, anticipates roughly 20% of annual EPS in H1 (about 15% in Q2), and warns refund timing and ongoing cost inflation (commodities, freight, CNY, supply disruption) could affect results.Helen Of Troy Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
54
Neutral
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.82B | 1.79B | 1.91B | 2.01B | 2.07B | 2.22B |
| Gross Profit | 825.54M | 815.69M | 914.41M | 948.66M | 899.35M | 953.19M |
| EBITDA | -261.21M | -727.80M | 268.61M | 301.32M | 286.94M | 310.88M |
| Net Income | -412.50M | -898.98M | 123.75M | 168.59M | 143.27M | 223.76M |
Balance Sheet | ||||||
| Total Assets | 2.08B | 2.12B | 3.13B | 2.84B | 2.91B | 2.82B |
| Cash, Cash Equivalents and Short-Term Investments | 24.18M | 18.89M | 18.87M | 18.50M | 29.07M | 33.38M |
| Total Debt | 771.35M | 833.70M | 956.84M | 702.93M | 977.08M | 856.96M |
| Total Liabilities | 1.24B | 1.32B | 1.45B | 1.20B | 1.42B | 1.50B |
| Stockholders Equity | 843.52M | 798.20M | 1.68B | 1.64B | 1.49B | 1.33B |
Cash Flow | ||||||
| Free Cash Flow | 80.49M | 131.91M | 83.14M | 269.42M | 33.38M | 62.78M |
| Operating Cash Flow | 112.16M | 171.14M | 113.21M | 306.07M | 208.24M | 140.82M |
| Investing Cash Flow | 47.54M | -34.43M | -263.09M | 5.45M | -319.33M | -438.91M |
| Financing Cash Flow | -160.69M | -136.69M | 150.25M | -322.09M | 106.78M | 286.35M |
Helen Of Troy Technical Analysis
Neutral
18.86
Price Trends
26.10
Positive
21.64
Positive
20.88
Positive
Market Momentum
0.32
Positive
47.44
Neutral
22.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HELE, the sentiment is Neutral. The current price of 18.86 is below the 20-day moving average (MA) of 27.75, below the 50-day MA of 26.10, and below the 200-day MA of 20.88, indicating a neutral trend. The MACD of 0.32 indicates Positive momentum. The RSI at 47.44 is Neutral, neither overbought nor oversold. The STOCH value of 22.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HELE.
Helen Of Troy Risk Analysis
Helen Of Troy disclosed 28 risk factors in its most recent earnings report. Helen Of Troy reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Helen Of Troy Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $33.23M | 13.94 | 21.40% | 9.81% | -4.13% | -18.10% | |
70 Outperform | $1.95B | 15.77 | 6.65% | 3.15% | -3.76% | 148.09% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $249.06M | 4.68 | 6.84% | 2.39% | -14.17% | ― | |
56 Neutral | $1.20B | -15.81 | -5.14% | 3.51% | -5.30% | -196.78% | |
54 Neutral | $638.90M | -1.49 | -94.52% | ― | -2.08% | -23.88% | |
50 Neutral | $122.23M | -16.65 | -9.41% | ― | -8.16% | 85.14% |
* Consumer Defensive Sector Average
HELE
Helen Of Troy
26.34
3.79
16.81%
NUS
Nu Skin
5.23
-3.76
-41.86%
SPB
Spectrum Brands Holdings
83.31
27.03
48.04%
UG
United-Guardian
7.17
-0.46
-5.99%
EPC
Edgewell Personal Care
26.48
0.16
0.62%
SKIN
Beauty Health
0.91
-1.00
-52.41%
Helen Of Troy Corporate Events
Business Operations and StrategyRegulatory Filings and Compliance
Helen of Troy Releases Fiscal 2026 Sustainability Report
Neutral
Jun 4, 2026
On June 4, 2026, Helen of Troy Limited released its fiscal year 2026 Sustainability Report, making the document available on its corporate website for investors and other stakeholders. The filing, signed the same day by Chief Financial Officer Bri...
Business Operations and StrategyRegulatory Filings and Compliance
Helen of Troy Updates Annual Employee Incentive Plan
Neutral
May 19, 2026
On May 13, 2026, Helen of Troy Limited’s Board of Directors approved an amended and restated Annual Incentive Plan to update administrative and technical elements of its employee bonus program. The plan is intended to promote the companyR...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.